Oncology Institute Inc
For the period ended Dec 31, 2023. Filed Mar 28, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 28, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned hereunto duly authorized, on this the day of March 28, 2024.
| THE ONCOLOGY INSTITUTE, INC. | |
|---|---|
| By: | /s/ Mihir Shah |
| Mihir Shah | |
| Chief Financial Officer(Duly Authorized Officer) | |
SIGNATURES AND POWER OF ATTORNEY
We, the undersigned officers and directors of The Oncology Institute, Inc., hereby severally constitute and appoint Daniel Virnich and Mihir Shah, and each of them singly (with full power to each of them to act alone), our true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution in each of them for him and in his name, place and stead, and in any and all capacities, to sign any and all amendments (including post-effective amendments) to this registration statement (or any other registration statement for the same offering that is to be effective upon filing pursuant to Rule 462(b) under the Securities Act of 1933), and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite or necessary to be done in and about the premises, as full to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities held on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ Daniel Virnich | ||
| Daniel Virnich | Chief Executive Officer (Principal Executive Officer) | March 28, 2024 |
| /s/ Mihir Shah | ||
| Mihir Shah | Chief Financial Officer (Principal Financial and Accounting Officer) | March 28, 2024 |
| /s/ Richard Barasch | ||
| Richard Barasch | Director | March 28, 2024 |
| /s/ Karen Johnson | ||
| Karen Johnson | Director | March 28, 2024 |
| /s/ Mohit Kaushal | ||
| Mohit Kaushal | Director | March 28, 2024 |
| /s/ Gabriel Ling | ||
| Gabriel Ling | Director | March 28, 2024 |
| /s/ Anne McGeorge | ||
| Anne McGeorge | Director | March 28, 2024 |
| /s/ Maeve O'Meara | ||
| Maeve O’Meara | Director | March 28, 2024 |
| Signature | Title | Date |
|---|---|---|
| /s/ Mark Pacala | ||
| Mark Pacala | Director | March 28, 2024 |
| /s/ Brad Hively | ||
| Brad Hively | Director | March 28, 2024 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.